rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
11	Hypotension	C0020649	4	129	4.20766976816e-10	1.8032786885245903e-05	TACR1,GHRL,GNA11,TAC1
31	Abnormality of the vitreous humor	C4025356	2	26	7.7816637023e-08	5.081967213114754e-05	GNA11,GNAQ
32	Zonular cataract	C1861821	2	28	9.79929872802e-08	5.245901639344263e-05	GNA11,GNAQ
34	Enteritis	C0014335	2	35	1.95517527057e-07	5.573770491803279e-05	TACR1,TAC1
35	Acute postoperative pain	C0030201	2	37	2.32008766088e-07	5.737704918032787e-05	TACR1,TAC1
36	Ectopia lentis, isolated autosomal recessive	C0013581	2	38	2.51801224316e-07	5.9016393442622956e-05	GNA11,GNAQ
37	Neoplasm of the eye	C0015414	2	40	2.94825636016e-07	6.0655737704918034e-05	GNA11,GNAQ
46	Fibromyalgia	C0016053	2	48	5.1537510537e-07	7.540983606557378e-05	TACR1,TAC1
47	Abnormal pupillary morphology	C0154936	2	51	6.20231103921e-07	7.704918032786885e-05	GNA11,GNAQ
49	Urticaria Pigmentosa	C0042111	2	53	6.97442361863e-07	8.032786885245902e-05	TACR1,TAC1
50	Bradycardia	C0428977	2	53	6.97442361863e-07	8.19672131147541e-05	TACR1,TAC1
51	Gorlin syndrome	C0004779	2	54	7.38340947826e-07	8.360655737704918e-05	TACR1,TAC1
52	Mastocytosis	C0024899	2	57	8.70574194067e-07	8.524590163934426e-05	TACR1,TAC1
53	Pain	C0030193	4	628	1.01485306903e-06	8.688524590163935e-05	TACR1,GNA11,TAC1,GNAQ
58	aggressive cancer	C2945759	2	67	1.42276205917e-06	9.508196721311476e-05	GNA11,GNAQ
69	Cough	C0010200	2	87	3.13678816866e-06	0.00011311475409836065	TACR1,TAC1
70	Acute lymphoid leukemia	C0023449	4	824	3.85972543926e-06	0.00011475409836065574	TACR1,GNB1,TAC1,GNA15
72	Neuralgia	C0027796	2	94	3.96193136221e-06	0.00011803278688524591	TACR1,TAC1
76	Anxiety Disorders	C0003469	3	383	5.85373699069e-06	0.00012459016393442623	TACR1,GNB1,TAC1
80	Prader-Willi syndrome	C0032897	2	109	6.18856054069e-06	0.00013114754098360657	GHRL,GNAQ
81	Retinal detachment	C0035305	2	111	6.53651638882e-06	0.00013278688524590162	GNA11,GNAQ
85	Irregular hyperpigmentation	C1860236	2	117	7.65754133725e-06	0.00013934426229508196	GNA11,GNAQ
94	Anorexia	C0003123	2	134	1.15073411673e-05	0.0001540983606557377	GHRL,TAC1
95	Pruritus	C0033774	2	138	1.2568289127e-05	0.0001557377049180328	TACR1,TAC1
103	Inflammatory abnormality of the eye	C4020969	2	155	1.77983993259e-05	0.00016885245901639346	GNA11,GNAQ
111	Monosomy	C0026499	2	158	1.884902427e-05	0.00018196721311475412	GNA11,GNAQ
114	Obstructive sleep apnea	C0520679	2	166	2.18489431388e-05	0.00018688524590163935	TACR1,TAC1
116	Depressive Disorder	C0011581	3	543	2.31665737348e-05	0.0001901639344262295	GHRL,GNB1,TAC1
117	Bronchial Hyperreactivity	C0085129	2	170	2.3460238323e-05	0.0001918032786885246	TACR1,TAC1
118	Nevus	C0497388	2	174	2.51481090583e-05	0.0001934426229508197	GNA11,GNAQ
119	Internal hemorrhage	C0333285	2	174	2.51481090583e-05	0.00019508196721311475	GNA11,GNAQ
121	Hyperpigmentation of the skin	C0162834	2	177	2.64652068364e-05	0.00019836065573770493	GNA11,GNAQ
122	Hyperalgesia	C0020429	2	177	2.64652068364e-05	0.0002	TACR1,TAC1
125	Neoplasm by anatomical site	C4023185	3	576	2.91982146409e-05	0.00020491803278688525	GNB1,GNA11,GNAQ
127	Abdominal pain	C0000737	2	187	3.11825700295e-05	0.0002081967213114754	GNA11,TAC1
128	Abnormality of blood circulation	C4023585	2	189	3.21879530346e-05	0.0002098360655737705	GNA11,GNAQ
129	Hyperphosphatemia	C0085681	1	25	3.28147290362e-05	0.0002114754098360656	GNA11
130	Drug Eruptions	C0011609	1	25	3.28147290362e-05	0.00021311475409836064	TAC1
131	Polyglandular Type I Autoimmune Syndrome	C0085859	1	25	3.28147290362e-05	0.00021475409836065575	GNA11
132	Globus Hystericus	C0017650	1	25	3.28147290362e-05	0.00021639344262295082	TAC1
133	Polycythemia vera	C0032463	2	192	3.37357159967e-05	0.0002180327868852459	TACR1,TAC1
134	Neoplasm by histology	C4023186	2	193	3.42624001312e-05	0.00021967213114754098	GNA11,GNAQ
135	Vomiting	C0042963	2	194	3.47943910992e-05	0.00022131147540983606	TACR1,TAC1
136	Peritoneal Mesothelioma	C0346109	1	26	3.55427779707e-05	0.00022295081967213117	GNA11
137	Chronic sciatica	C0036396	1	26	3.55427779707e-05	0.00022459016393442624	TAC1
138	Bulimia	C0006370	1	27	3.83792057416e-05	0.0002262295081967213	GHRL
139	Intraocular melanoma	C0220633	2	206	4.16082922942e-05	0.0002278688524590164	GNA11,GNAQ
140	Melanoma	C0025202	5	2386	4.26650801287e-05	0.00022950819672131148	TACR1,GNA11,TAC1,GNAQ,GNG2
141	Pituitary dependent hypercortisolism	C0221406	1	29	4.43768429328e-05	0.0002311475409836066	GHRL
142	Neoplasms	C0027651	3	646	4.57363944443e-05	0.00023278688524590164	GNB1,GNA11,GNAQ
143	Inflammation	C0021368	3	647	4.60135585679e-05	0.00023442622950819672	TACR1,GHRL,TAC1
144	Anxiety	C0003467	2	214	4.66063355916e-05	0.00023606557377049182	GNA11,TAC1
145	Hemiplegia	C0018991	1	31	5.08071553774e-05	0.00023770491803278687	GNAQ
146	Malignant melanoma of eye	C0558356	1	31	5.08071553774e-05	0.00023934426229508195	GNAQ
147	Hemorrhagic disorder due to intrinsic circulating anticoagulants	C0019087	1	32	5.41843998833e-05	0.00024098360655737706	GNAQ
148	Alcohol dependence	C0001973	3	675	5.42898485626e-05	0.00024262295081967214	TACR1,GHRL,TAC1
149	Colitis, Ulcerative	C0009319	3	679	5.55557709472e-05	0.0002442622950819672	TACR1,GHRL,TAC1
150	Asymptomatic Infections	C0275522	1	33	5.76696593557e-05	0.0002459016393442623	TAC1
151	Asthma	C0004096	4	1454	6.09756278391e-05	0.0002475409836065574	TACR1,GHRL,GNB1,TAC1
152	Excessive salivation	C0037036	1	34	6.12628460915e-05	0.00024918032786885245	TAC1
153	Venous insufficiency	C0042485	1	34	6.12628460915e-05	0.00025081967213114756	GNAQ
154	Cushing's syndrome	C0010481	1	34	6.12628460915e-05	0.00025245901639344266	GHRL
155	 {Nicotine dependence, protection against}, 188890 (3)	C0439857	1	34	6.12628460915e-05	0.0002540983606557377	GHRL
156	Mucosal telangiectasiae	C4022020	1	34	6.12628460915e-05	0.00025573770491803277	GNAQ
157	Ovarian Diseases	C0029928	2	236	6.23482449681e-05	0.0002573770491803279	GHRL,GNAQ
158	Hemianopia	C0018979	1	35	6.49638996831e-05	0.000259016393442623	GNAQ
159	Asymmetric growth	C4022025	1	35	6.49638996831e-05	0.00026065573770491803	GNAQ
160	heavy drinking	C0687132	1	35	6.49638996831e-05	0.00026229508196721314	GHRL
161	Churg-Strauss Syndrome	C0008728	1	36	6.87727579071e-05	0.0002639344262295082	GHRL
162	Hypoparathyroidism - autosomal dominant	C0342345	1	36	6.87727579071e-05	0.00026557377049180324	GNA11
163	Buphthalmos	C0020302	1	36	6.87727579071e-05	0.0002672131147540984	GNAQ
164	Corneal Diseases	C0010034	1	37	7.26893632274e-05	0.00026885245901639345	TAC1
165	alcohol use disorder	C0001956	1	38	7.67136231984e-05	0.00027049180327868856	TACR1
166	Acute disease of cardiovascular system	C0001314	1	38	7.67136231984e-05	0.0002721311475409836	TAC1
167	Sarcoidosis	C0036202	2	257	8.0302871843e-05	0.00027377049180327866	TACR1,TAC1
168	Pancreatitis, Acute Necrotizing	C0267941	1	39	8.08456236281e-05	0.0002754098360655738	TACR1
169	Bulimia nervosa 1	C2267227	1	39	8.08456236281e-05	0.00027704918032786887	GHRL
170	Progressive myositis ossificans	C0016037	1	39	8.08456236281e-05	0.0002786885245901639	TAC1
171	Gastroesophageal reflux	C0017168	2	258	8.12331942529e-05	0.00028032786885245903	TACR1,TAC1
172	Neuropathogenesis	C1518296	1	40	8.50851024193e-05	0.0002819672131147541	TAC1
173	Cutaneous malignant melanoma 3	C0151779	2	264	8.6964387657e-05	0.0002836065573770492	GNA11,GNAQ
174	Low back pain	C0024031	1	41	8.94321718728e-05	0.0002852459016393443	TAC1
175	Disseminated neuroblastoma	C1135161	1	42	9.38866269646e-05	0.00028688524590163934	TAC1
176	Congestive heart failure	C0018802	3	782	9.62631483871e-05	0.00028852459016393445	GHRL,GNA11,GNAQ
177	Left ventricular hypertrophy	C0149721	2	274	9.7094676342e-05	0.0002901639344262295	TAC1,GNAQ
178	Decreased activity of 3-hydroxyacyl-CoA dehydrogenase	C0086439	1	43	9.84485225123e-05	0.00029180327868852455	TAC1
179	Pancreatitis	C0030305	2	277	0.000100277720952	0.0002934426229508197	TACR1,GHRL
180	Chronic pain	C0150055	1	44	0.000103117742625	0.00029508196721311476	TAC1
181	Heart Failure	C0018801	3	803	0.000106691006362	0.0002967213114754098	GHRL,GNAQ,GNA15
182	Pituitary corticotropic cell adenoma	C1306214	1	45	0.00010789422397	0.0002983606557377049	GHRL
183	Capillary hemangiomas	C0206733	1	45	0.00010789422397	0.0003	GNAQ
184	Neuronal ceroid lipofuscinosis	C0027877	1	48	0.000122866761562	0.00030163934426229513	TAC1
185	Ulcerative colitis	C0009324	3	837	0.000125297497915	0.0003032786885245902	TACR1,GHRL,TAC1
186	Respiratory Syncytial Virus Infections	C0035235	2	299	0.000125729638202	0.00030491803278688524	TACR1,TAC1
187	Adenocarcinoma Of Esophagus	C0279628	2	300	0.000126977245378	0.00030655737704918034	GHRL,TAC1
188	Ganglioneuroblastoma	C0206718	1	49	0.000128071835838	0.0003081967213114754	TAC1
189	Exostoses	C0015302	1	49	0.000128071835838	0.0003098360655737705	GNAQ
190	Glucose intolerance	C0271650	2	304	0.000132048356425	0.0003114754098360656	GHRL,TAC1
191	Abnormality of the iris	C4025845	2	304	0.000132048356425	0.00031311475409836066	GNA11,GNAQ
192	Hypocalcemia	C0020598	1	51	0.000138802726987	0.00031475409836065576	GNA11
193	Abnormal peripheral nervous system synaptic transmission	C4021046	1	51	0.000138802726987	0.0003163934426229508	GNA11
194	Abnormal synaptic transmission	C4021083	1	51	0.000138802726987	0.0003180327868852459	GNA11
195	Abnormal synaptic transmission at the neuromuscular junction	C4025618	1	51	0.000138802726987	0.000319672131147541	GNA11
196	Abnormality of phosphate homeostasis	C4022032	1	52	0.000144328478865	0.0003213114754098361	GNA11
197	Hyperostosis	C0020492	1	52	0.000144328478865	0.00032295081967213113	GNAQ
198	Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	C0393819	1	52	0.000144328478865	0.00032459016393442624	TAC1
199	Abnormality of urine calcium concentration	C4023434	1	52	0.000144328478865	0.0003262295081967213	GNA11
200	Primary hyperparathyroidism	C0221002	1	53	0.000149961099228	0.0003278688524590164	GNA11
201	Abnormal bleeding	C1458140	2	319	0.00015224212199	0.0003295081967213115	GNA11,GNAQ
202	Nausea	C0027497	1	54	0.000155700440692	0.00033114754098360655	TACR1
203	Mood Disorders	C0525045	2	322	0.00015650861272	0.00033278688524590166	TACR1,TAC1
204	Abnormality of refraction	C4025843	2	325	0.000160852528438	0.0003344262295081967	GNA11,GNAQ
205	Pneumonitis	C3714636	1	55	0.0001615465025	0.0003360655737704918	TAC1
206	Abnormality of intracranial pressure	C4022809	1	56	0.00016749910658	0.0003377049180327869	GNA11
207	Arnold-Chiari malformation	C0003803	1	56	0.00016749910658	0.00033934426229508197	GNAQ
208	Focal dystonia	C0743332	1	56	0.00016749910658	0.000340983606557377	GNA11
209	Sicca Syndrome	C0086981	1	56	0.00016749910658	0.00034262295081967213	TACR1
210	Pulmonary hypertension, neonatal, susceptibility to	C0020542	2	333	0.000172819401256	0.00034426229508196723	TACR1,TAC1
211	Chronic neutrophilia	C3665444	1	57	0.000173558397148	0.0003459016393442623	TAC1
212	Hydrops, lactic acidosis, and sideroblastic anemia	C0013604	2	335	0.000175899322173	0.0003475409836065574	TAC1,GNAQ
213	Stomach Neoplasms	C0038356	3	916	0.000177585182559	0.00034918032786885244	GNA14,GHRL,TAC1
214	Abnormal pulmonary vein morphology	C0241665	1	58	0.000179724024963	0.00035081967213114755	GNAQ
215	Arrhythmias, Cardiac	C0003811	2	338	0.000180585907706	0.00035245901639344266	GNA11,GNAQ
216	Hypermelanotic macule	C1842774	1	59	0.000185996275168	0.0003540983606557377	GNAQ
217	Increased intracranial pressure	C0151740	1	59	0.000185996275168	0.0003557377049180328	GNA11
218	Abnormality of skin pigmentation	C1260926	2	344	0.000190202153448	0.00035737704918032786	GNA11,GNAQ
219	Sarcoidosis, Pulmonary	C0036205	1	60	0.000192374859115	0.0003590163934426229	TAC1
220	Osteoarthritis	C0029408	3	942	0.000197833358848	0.0003606557377049181	TACR1,TAC1,GNAQ
221	Memory Loss	C0002622	1	61	0.000198859744829	0.00036229508196721313	TAC1
222	Blindness	C0456909	2	352	0.000203535360922	0.00036393442622950823	GNA11,GNAQ
223	Helminthiasis	C0018889	1	63	0.000212148324354	0.0003655737704918033	TAC1
224	Microsatellite Instability	C0796369	1	63	0.000212148324354	0.00036721311475409834	GHRL
225	Hemiparesis	C0018989	1	63	0.000212148324354	0.0003688524590163935	GNAQ
226	Persistent infection	C1264606	1	63	0.000212148324354	0.00037049180327868855	TAC1
227	Corneal dystrophy, Fuchs endothelial 1	C0010036	1	64	0.000218951870539	0.0003721311475409836	GNAQ
228	Papule	C0332563	1	65	0.000225861535896	0.0003737704918032787	GNAQ
229	Crohn Disease	C0010346	3	979	0.000229486327583	0.00037540983606557376	TACR1,GHRL,TAC1
230	Myasthenia, limb-girdle, familial	C0947912	1	67	0.000239998987376	0.0003770491803278688	GNA11
231	Abnormality of the uvea	C4025842	2	373	0.000241397711594	0.00037868852459016397	GNA11,GNAQ
232	Schizophrenia	C0036341	4	1947	0.000245792196035	0.000380327868852459	TACR1,GHRL,GNB1,TAC1
233	Hyperparathyroidism 4	C0020502	1	68	0.000247226511833	0.0003819672131147541	GNA11
234	Hereditary pancreatitis	C0238339	2	377	0.000249092290217	0.0003836065573770492	TACR1,TAC1
235	Tumor Progression	C0178874	4	1969	0.000259221812944	0.00038524590163934423	TACR1,GNA11,TAC1,GNAQ
236	Common Migraine	C0338480	1	70	0.000261999281584	0.0003868852459016394	TAC1
237	Acromegaly	C0001206	1	70	0.000261999281584	0.00038852459016393444	GHRL
238	Uremia	C0041948	1	72	0.000277195010772	0.0003901639344262295	GHRL
239	Granulomatosis with Polyangiitis	C3495801	1	74	0.000292813193583	0.0003918032786885246	GHRL
240	Eating disorder	C0013473	1	75	0.000300780654104	0.00039344262295081965	GHRL
241	Gingival overgrowth	C0376480	1	75	0.000300780654104	0.00039508196721311476	GNAQ
242	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	C0029124	2	402	0.000300820380527	0.00039672131147540986	GNA11,GNAQ
243	Hypercalciuria	C0020438	1	76	0.000308853464071	0.0003983606557377049	GNA11
244	Nephrocalcinosis	C0027709	1	76	0.000308853464071	0.0004	GNA11
245	Ichthyosis bullosa of Siemens	C0432306	1	77	0.000317031792896	0.00040163934426229507	TAC1
246	Abnormal concentration of calcium in blood	C0004268	1	78	0.000325315378901	0.0004032786885245902	GNA11
247	Drug Allergy	C0013182	1	79	0.000333704219909	0.0004049180327868853	TAC1
248	Abnormal thrombosis	C4025731	1	79	0.000333704219909	0.00040655737704918033	GNAQ
249	Abnormality of the optic disc	C3808249	2	420	0.000342082817931	0.0004081967213114754	GNA11,GNAQ
250	Panic disorder 1	C1868649	1	80	0.000342198342078	0.0004098360655737705	TACR1
251	Substance Withdrawal Syndrome	C0038587	1	80	0.000342198342078	0.0004114754098360656	TACR1
252	Secondary hypertriglyceridemia	C0027627	5	3444	0.000343856987469	0.0004131147540983607	TACR1,GNA11,TAC1,GNAQ,GNA15
253	Infarction, Middle Cerebral Artery	C0740392	1	83	0.000368311381633	0.00041475409836065575	GHRL
254	Verotoxigenic Escherichia coli gastrointestinal tract infection	C0009450	3	1111	0.0003729013062	0.0004163934426229508	TACR1,GHRL,TAC1
255	Chronic heart failure	C0264716	1	84	0.000377225720556	0.0004180327868852459	GHRL
256	Mental disorders	C0004936	2	439	0.000389447598258	0.000419672131147541	TACR1,TAC1
257	Intervertebral disc degeneration	C0158266	1	86	0.000395369268448	0.00042131147540983607	GNAQ
258	Carcinoid tumor no ICD-O subtype	C0334299	1	87	0.000404598299605	0.0004229508196721312	GHRL
259	Plasmacytoma	C0032131	1	89	0.000423370463134	0.0004245901639344262	GNA15
